Immune-Related Adverse Events of Tislelizumab in 120 Patients with Hepatocellular Carcinoma
LIANG Fanglin, CHEN Lingyuan, HU Danli, WEI Lingyun, WEI Tiemeng, ZHANG Faen, WEI Yana
Chinese Journal of Pharmacovigilance . 2025, (6): 659 -663 .  DOI: 10.19803/j.1672-8629.20240987